Brenetafusp and monoclonal antibodies and chemotherapy clinical trials

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

This study is testing a new medicine called brenetafusp for people with certain advanced solid cancers that haven't responded to other treatments. It checks how safe and effective brenetafusp is, both alone and with other common cancer drugs.